Ferrero B - Search Results

1

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab.

Barbero P, Bergui M, Versino E, Ricci A, Zhong JJ, Ferrero B, Clerico M, Pipieri A, Verdun E, Giordano L, Durelli L; INCOMIN Trial Study Group. Barbero P, et al. Among authors: ferrero b. Mult Scler. 2006 Feb;12(1):72-6. doi: 10.1191/135248506ms1247oa. Mult Scler. 2006. PMID: 16459722 Clinical Trial.

2

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.

Durelli L, Barbero P, Bergui M, Versino E, Bassano MA, Verdun E, Ferrero B, Rivoiro C, Ferrero C, Picco E, Ripellino P, Viglietti D, Giuliani G, Montanari E, Clerico M; OPTIMS Study Group. Durelli L, et al. Among authors: ferrero c, ferrero b. J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25. J Neurol. 2008. PMID: 18825438 Clinical Trial.

3

Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function.

Durelli L, Bongioanni MR, Cavallo R, Ferrero B, Ferri R, Verdun E, Bradac GB, Riva A, Geuna M, Bergamini L, et al. Durelli L, et al. Among authors: ferrero b. Mult Scler. 1995;1 Suppl 1:S32-7. Mult Scler. 1995. PMID: 9345396 Clinical Trial.

4

Long term recombinant interferon alpha treatment in MS with special emphasis to side effects.

Durelli L, Bongioanni MR, Ferrero B, Imperiale D, Verdun E, Oggero A, Gentile E, Bradac GB, Bergui M, Bergamini L, Bergamasco B. Durelli L, et al. Among authors: ferrero b. Mult Scler. 1996 Jul;1(6):366-71. doi: 10.1177/135245859600100617. Mult Scler. 1996. PMID: 9345419 Clinical Trial.

5

Autoimmune events during interferon beta-1b treatment for multiple sclerosis.

Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G. Durelli L, et al. Among authors: ferrero b. J Neurol Sci. 1999 Jan 1;162(1):74-83. doi: 10.1016/s0022-510x(98)00299-8. J Neurol Sci. 1999. PMID: 10064173 Clinical Trial.

6

Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.

Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M; Betaferon Safety Trial (BEST) Study Group. Durelli L, et al. Among authors: ferrero b. Neurology. 2001 Oct 23;57(8):1363-70. doi: 10.1212/wnl.57.8.1363. Neurology. 2001. PMID: 11673572 Clinical Trial.

7

Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?

Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L; Betaferon Safety Trial (BEST) Study Group. Verdun E, et al. Among authors: ferrero b. J Interferon Cytokine Res. 2002 Feb;22(2):245-55. doi: 10.1089/107999002753536220. J Interferon Cytokine Res. 2002. PMID: 11911808

8

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

Cucci A, Barbero P, Clerico M, Ferrero B, Versino E, Contessa G, Demercanti S, Viglietta E, Di Liberto A, Vai AG, Durelli L. Cucci A, et al. Among authors: ferrero b. J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23. J Neuroimmunol. 2010. PMID: 20573405 Clinical Trial.

9

Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment.

Durelli L, Bongioanni MR, Ferrero B, Ferri R, Imperiale D, Bradac GB, Bergui M, Geuna M, Bergamini L, Bergamasco B. Durelli L, et al. Among authors: ferrero b. Neurology. 1996 Jul;47(1):123-9. doi: 10.1212/wnl.47.1.123. Neurology. 1996. PMID: 8710065 Clinical Trial.

10

Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis.

Bongioanni MR, Durelli L, Ferrero B, Imperiale D, Oggero A, Verdun E, Aimo G, Pagni R, Geuna M, Bergamasco B. Bongioanni MR, et al. Among authors: ferrero b. J Neurol Sci. 1996 Nov;143(1-2):91-9. doi: 10.1016/s0022-510x(96)00176-1. J Neurol Sci. 1996. PMID: 8981304 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page